These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Does short-term fasting desensitize human somatotrophs to oral L-dopa stimulation?
    Author: Röjdmark S.
    Journal: Clin Endocrinol (Oxf); 1986 Dec; 25(6):721-8. PubMed ID: 3652472.
    Abstract:
    To investigate whether short-term fasting influences hormone release from human somatotrophs and lactotrophs, two oral L-dopa tests, using 0.5 g L-dopa, were carried out in seven normal subjects. The first test was performed after an overnight fast (8 h), the second after an additional 48 h of total food withdrawal. Basal blood glucose declined by 21 +/- 2% (mean +/- SEM) between the two tests (P less than 0.001). Free T3 in serum (FT3) fell by 32 +/- 4% (P less than 0.001). GH responsiveness to L-dopa--as reflected by the GH incremental area (ng/ml X min)--decreased from 588 +/- 162 to 24 +/- 240 (P less than 0.02). The latter response area did not even differ significantly from zero. Food deprivation failed to affect the lactotrophs, inasmuch as similar PRL decremental areas (ng/ml X min) were obtained in response to L-dopa before (704 +/- 165) and after (686 +/- 128) the prolonged fast. In order to prevent blood glucose from falling significantly during the period of food deprivation eight additional normal subjects were given 9 small oral doses of glucose (each dose 0.5 g/kg) at regular intervals between the two L-dopa tests. This resulted in similar FT3 concentrations before and after the prolonged fast. Furthermore, glucose supplementation restored normal GH responsiveness to L-dopa, as evidenced by similar GH incremental areas before and after the glucose fast. These results imply that short-term fasting desensitizes human somatotrophs to exogenous L-dopa. The finding that the decreased GH responsiveness returns to normal if a decline in FT3 is prevented by oral glucose supplementation, suggests that changes in FT3 might contribute to the abolished GH responsiveness to L-dopa in fasting.
    [Abstract] [Full Text] [Related] [New Search]